A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells
出版年份 2019 全文链接
标题
A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-23
DOI
10.1038/s41598-018-36728-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
- (2018) Cherine Abou Faycal et al. BRITISH JOURNAL OF CANCER
- Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy
- (2017) Cherine Abou-Fayçal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ground rules of the pluripotency gene regulatory network
- (2017) Mo Li et al. NATURE REVIEWS GENETICS
- The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
- (2017) Guangxian Zhao et al. Aging and Disease
- Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production1
- (2016) Kirsten R. Palmer et al. BIOLOGY OF REPRODUCTION
- Genetic alteration profiling of patients with resected squamous cell lung carcinomas
- (2016) Dan Tao et al. Oncotarget
- Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer
- (2015) Rebecca S. Heist et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
- (2015) Sara M. Tolaney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternative Splicing of MBD2 Supports Self-Renewal in Human Pluripotent Stem Cells
- (2014) Yu Lu et al. Cell Stem Cell
- Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
- (2014) M. Larrayoz et al. EMBO Molecular Medicine
- The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2
- (2014) Xia Xu et al. GENES & DEVELOPMENT
- VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
- (2014) D Zhao et al. ONCOGENE
- NOTCH Decoys That Selectively Block DLL/NOTCH or JAG/NOTCH Disrupt Angiogenesis by Unique Mechanisms to Inhibit Tumor Growth
- (2014) Thaned Kangsamaksin et al. Cancer Discovery
- A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing
- (2013) Tetsuya Saito et al. FEBS LETTERS
- Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer
- (2012) Jeffrey A. Meyerhardt et al. PLoS One
- Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
- (2012) Stephanie Gout et al. PLoS One
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1
- (2011) J.-N. Boeckel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer
- (2010) D. G. Duda et al. ONCOLOGIST
- A Recently Evolved Novel Trophoblast-Enriched Secreted Form of fms-Like Tyrosine Kinase-1 Variant Is Up-Regulated in Hypoxia and Preeclampsia
- (2009) Christie P. Thomas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
- (2009) Christopher G. Willett et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- The SR protein family of splicing factors: master regulators of gene expression
- (2008) Jennifer C. Long et al. BIOCHEMICAL JOURNAL
- A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through 5 1 integrin
- (2008) S. Soro et al. BLOOD
- E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35
- (2008) G Merdzhanova et al. CELL DEATH AND DIFFERENTIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now